• Canagliflozin/metformin, sold under the brand name Vokanamet among others, is a fixed-dose combination anti-diabetic medication used for the treatment...
    7 KB (438 words) - 05:00, 6 July 2024
  • Thumbnail for Canagliflozin
    disease. Canagliflozin decreases HbA1c levels by 0.77% to 1.16% when given by itself, in combination with metformin, in combination with metformin and a...
    29 KB (2,960 words) - 20:56, 4 September 2024
  • Thumbnail for Metformin
    Metformin, sold under the brand name Glucophage, among others, is the main first-line medication for the treatment of Type 2 diabetes, particularly in...
    151 KB (14,475 words) - 01:04, 25 October 2024
  • Sitagliptin/metformin, sold under the brand name Janumet among others, is a fixed-dose combination anti-diabetic medication used to treat type 2 diabetes...
    11 KB (777 words) - 05:13, 27 October 2024
  • Dapagliflozin/metformin, sold under the brand name Xigduo Xr among others, is a fixed-dose combination anti-diabetic medication used as an adjunct to...
    10 KB (472 words) - 03:59, 6 July 2024
  • Empagliflozin/metformin, sold under the brand name Synjardy among others, is a fixed-dose combination anti-diabetic medication used to treat type 2 diabetes...
    9 KB (556 words) - 05:32, 18 July 2024
  • Thumbnail for Dapagliflozin
    to recommend they be stopped temporarily before scheduled surgery. Canagliflozin, dapagliflozin, and empagliflozin should each be stopped at least three...
    53 KB (4,975 words) - 03:43, 30 September 2024
  • Pioglitazone/metformin, sold under the brand name Actoplus Met among others, is a fixed-dose combination anti-diabetic medication used to improve glycemic...
    7 KB (536 words) - 05:58, 18 March 2024
  • Glibenclamide/metformin, also known as glyburide/metformin and sold under the brand name Glucovance, is a fixed-dose combination anti-diabetic medication...
    5 KB (184 words) - 11:47, 3 November 2024
  • Thumbnail for Meglitinide
    infarction, non-fatal stroke or end-stage renal disease when comparing metformin monotherapy to meglitinide for the treatment of type 2 diabetes. They...
    4 KB (345 words) - 21:52, 3 April 2023
  • Thumbnail for Vildagliptin
    Agency has also approved a combination of vildagliptin and metformin, vildagliptin/metformin (Eucreas by Novartis) as an oral treatment for type-2 diabetes...
    8 KB (688 words) - 06:01, 17 June 2024
  • Thumbnail for Gliclazide
    cannot be controlled by proper dietary management and exercise and when metformin has already been tried. National Kidney Foundation (2012 Update) claims...
    18 KB (1,514 words) - 15:51, 7 June 2024
  • September 2015, the FDA issued a warning related to canagliflozin (Invokana) and canagliflozin/metformin (Invokamet) due to decreased bone mineral density...
    44 KB (4,537 words) - 07:53, 5 November 2024
  • Thumbnail for Dipeptidyl peptidase-4 inhibitor
    infarction, non-fatal stroke or end-stage renal disease when comparing metformin monotherapy to dipeptidyl peptidase-4 inhibitors for the treatment of...
    16 KB (1,798 words) - 07:40, 1 February 2024
  • Thumbnail for Dulaglutide
    in combination with other medicines for type 2 diabetes, in particular metformin, sulfonylureas, thiazolidinediones, and insulin taken concomitantly with...
    16 KB (1,542 words) - 20:53, 21 September 2024
  • Thumbnail for Alogliptin
    commonly used in combination with metformin in people whose diabetes cannot adequately be controlled with metformin alone. In April 2016, the U.S. Food...
    12 KB (894 words) - 22:13, 31 March 2024
  • Thumbnail for Exenatide
    potentially other antidiabetic medication. It is a treatment option after metformin and sulfonylureas. It is given by injection under the skin. Common side...
    31 KB (2,842 words) - 16:57, 5 November 2024
  • type 2 diabetes as an adjunct to diet and exercise; as monotherapy when metformin is considered inappropriate due to intolerance; in addition to other medicinal...
    41 KB (3,676 words) - 19:19, 4 October 2024
  • Thumbnail for Repaglinide
    combination therapy of repaglinide together with the generic anti-diabetic drug metformin. This new patent was due to expire June 2018. In January 2011, a federal...
    10 KB (990 words) - 13:31, 19 December 2023
  • Thumbnail for Semaglutide
    "Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes". ClinicalTrials.gov. October 2019. Archived...
    72 KB (6,068 words) - 21:55, 6 November 2024
  • approved in 2019, consisting of metformin, saxagliptin, and dapagliflozin. Another triple combination approval for metformin, linagliptin, and empagliflozin...
    51 KB (5,305 words) - 19:29, 4 November 2024
  • Thumbnail for Empagliflozin/linagliptin
    older with type 2 diabetes mellitus: to improve glycemic control when metformin and/or sulphonylurea (SU) and empagliflozin or linagliptin do not provide...
    9 KB (467 words) - 06:10, 16 July 2024
  • Thumbnail for Linagliptin
    conjunction with exercise and diet. It is generally less preferred than metformin and sulfonylureas as an initial treatment. It is taken by mouth. Common...
    11 KB (607 words) - 05:27, 10 June 2024
  • Thumbnail for Liraglutide
    a second-line therapy for diabetes following first-line therapy with metformin. Its effects on long-term health outcomes like heart disease and life...
    32 KB (2,752 words) - 00:10, 2 November 2024
  • Thumbnail for Tirzepatide
    Alogliptin/metformin Canagliflozin/metformin Cagrilintide/semaglutide§ Dapagliflozin/metformin Dapagliflozin/saxagliptin Dapagliflozin/saxagliptin/metformin...
    44 KB (3,512 words) - 16:20, 8 November 2024
  • Thumbnail for Retatrutide
    Alogliptin/metformin Canagliflozin/metformin Cagrilintide/semaglutide§ Dapagliflozin/metformin Dapagliflozin/saxagliptin Dapagliflozin/saxagliptin/metformin...
    4 KB (328 words) - 05:24, 6 August 2024
  • Thumbnail for Pioglitazone
    anti-diabetic medication used to treat type 2 diabetes. It may be used with metformin, a sulfonylurea, or insulin. Use is recommended together with exercise...
    28 KB (2,663 words) - 03:58, 30 September 2024
  • Vildagliptin/metformin, sold under the brand name Eucreas among others, is a fixed-dose combination anti-diabetic medication for the treatment of type...
    6 KB (402 words) - 13:08, 16 July 2024
  • Thumbnail for Saroglitazar
    Alogliptin/metformin Canagliflozin/metformin Cagrilintide/semaglutide§ Dapagliflozin/metformin Dapagliflozin/saxagliptin Dapagliflozin/saxagliptin/metformin...
    9 KB (746 words) - 07:01, 29 May 2024
  • Thumbnail for Insulin aspart
    Alogliptin/metformin Canagliflozin/metformin Cagrilintide/semaglutide§ Dapagliflozin/metformin Dapagliflozin/saxagliptin Dapagliflozin/saxagliptin/metformin...
    24 KB (1,877 words) - 07:44, 5 October 2024